A superb source of investment clues can be gleaned from an individual company’s earnings call transcript. Read More
Dr. Joe Duarte is Chief Investment Strategist and Editor of Profit Catalyst Alert and Weekly Cash Machine. He has been a professional investor and independent analyst since 1990. He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.
Analyst Articles
Contrary to popular myth, China is on the downslope and America is ascendant. Here’s a closer look at how the red dragon is losing its fire. Read More
The utilities sector was the worst performing in 2023, but in 2022 it was among the best. Over time, utilities stocks offer solid returns. Read More
Factors remain in place to sustain the stock market rally, but an undercurrent of caution has crept into trading as risks increase. Read More
Twenty years ago, the U.S. faced a natural gas shortage. Today, the situation is different than envisioned by even the major energy companies. Read More
Research confirms the power of marijuana in pain management and treating substance abuse. Big Pharma should be worried. Read More
These mega-cap tech stocks account for about 60% of the S&P 500's strong rise over the past 12 months. Can the seven stay in the saddle? Read More
Leverage can be useful, if applied properly. Here’s a look at certain types of loans that are rip-offs. Read More
Jobs growth and tech profits paint a rosy, not red-hot, picture. We parse the latest economic data. Read More
Nike's revised guidance for this year caught Wall Street off guard, paving the way for a very profitable trade. Read More